ArticleOncoTargets and therapy2015

Baseline blood immunological profiling differentiates between Her2-breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response.

Oana Tudoran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.